Language

Zafgen Inc To Discuss ZGN-1061 Phase 2 Data Corporate Call

Conference Call Zafgen Inc

Zafgen Inc Conference call will be held on Jun 25, 2018. During the earnings conference call's session Zafgen Inc will provide updated information and financial status.

Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.

In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Zafgen Inc for this information

Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.

We are a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders. Beloranib, our lead product candidate, is a novel, first-in-class, twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including severe obesity in two rare diseases, Prader-Willi syndrome, or PWS, and hypothalamic injury-associated obesity, or HIAO, including craniopharyngioma-associated obesity. We are also developing ZGN-839, a liver-targeted methionine aminopeptidase 2, or MetAP2, inhibitor, for the treatment of nonalcoholic steatohepatitis, or NASH, and abdominal obesity, as well as other second-generation methionine aminopeptidase 2, or MetAP2, inhibitors for the treatment of severe obesity. In December 2015, the U.S.